NRIX Nurix Therapeutics, Inc.: institutional ownership and insider trading
220 funds reported holding $2.97B of Nurix Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $5.83M, with 43 new positions and 28 funds selling out; over the last 12 months insiders bought $0 and sold $5.23M on the open market.
Famous investors holding NRIX
- Cathie Wood (ARK Investment Management): $43.5M, 0.3% of the portfolio
- Ken Griffin (Citadel Advisors): $37.1M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.48M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $507K, 0.0% of the portfolio
Largest institutional holders of NRIX
- BlackRock, Inc. (BLK) — $213M
- Vestal Point Capital, LP — $195M
- Deep Track Capital, LP — $188M
- Rubric Capital Management LP — $175M
- FMR LLC — $133M
- PRICE T ROWE ASSOCIATES INC /MD/ — $132M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $116M
- STATE STREET CORP (STT, STT-PG) — $113M
- BAKER BROS. ADVISORS LP — $113M
- VANGUARD GROUP INC — $113M
Recent NRIX insider trades
- Oct 15, 2026: Hansen Gwenn sold 1,452 shares ($36.3K)
- Oct 14, 2026: Gregory Julia P sold 22,583 shares ($529K)
- Oct 2, 2026: Ring Christine sold 5,786 shares ($134K)
- Sep 2, 2026: Ring Christine sold 5,787 shares ($149K)
5%+ owners
- Redmile Group, LLC: 8.1% (Schedule 13G/A, filed Aug 14, 2026)
- Vestal Point Capital, LP: 7.8% (Schedule 13G/A, filed Aug 14, 2026)
- Deep Track Capital, LP: 7.5% (Schedule 13G/A, filed Aug 14, 2026)
- Rubric Capital Management LP: 7.0% (Schedule 13G, filed Aug 14, 2026)
- FMR LLC: 5.4% (Schedule 13G, filed May 6, 2026)
- Perceptive Advisors LLC: 5.3% (Schedule 13G, filed Sep 23, 2026)